Search

Your search keyword '"Yoshida, Yoichiro"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Yoshida, Yoichiro" Remove constraint Author: "Yoshida, Yoichiro" Database Unpaywall Remove constraint Database: Unpaywall
99 results on '"Yoshida, Yoichiro"'

Search Results

2. A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer

4. The frequency of ctDNA with KRAS, NRAS, and BRAF mutations in colorectal cancer is associated with the mutation site

6. Demonstration of equivocal anti-glomerular basement membrane antibody positivity as a non-specific reaction through multiple immunologic assays in a case of pediatric asymptomatic hematuria

7. Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)

8. TaTME for Abdominoperineal Excision

9. Analysis of Circulating DNA to Assess Prognoses for Metastatic Colorectal Cancer Patients Treated with Regorafenib Dose-Escalation Therapy: A Retrospective, Exploratory Analysis of the RECC Trial

10. Detection of carbon dioxide embolism by transesophageal echocardiography during transanal/perineal endoscopic surgery: a pilot study

11. MO36-4 Asian subgroup analysis in global POLAR program of calmangafodipir on top of mFOLFOX6 for the prevention of CIPN

13. Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study)

14. Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer

15. A Trial Protocol of Precision Medicine for Patients with RAS Wild Metastatic Colorectal Cancer Using Liquid Biopsy (RAS-liquid Study): A Prospective, Multicenter Observational Study

17. Intraoperative pressure monitoring of the lower leg for preventing compression-related complications associated with the lithotomy position

18. Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer

24. A Case of Perihilar Cholangiocarcinoma Occurring 49 Years after Surgery for Congenital Biliary Duct Dilatation and 28 Years after Pancreaticoduodenectomy for Pancreatic Duct Stones

25. A case of carbon dioxide embolism during the transperineal approach in total pelvic exenteration for advanced anorectal cancer

26. Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy

27. Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion

29. Avoiding urethral and rectal injury during transperineal abdominoperineal resection in male patients with anorectal cancer

31. Safety and effectiveness of high ligation of the inferior mesenteric artery for cancer of the descending colon under indocyanine green fluorescence imaging: a pilot study

32. Acute chemotherapy-induced peripheral neuropathy due to oxaliplatin administration without cold stimulation

33. 5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine

34. The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy

36. A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)

37. Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)

38. Severe gastrointestinal involvement predictive score in IgA vasculitis is also a risk factor for nephritis being varied depending on their ages of onset

39. Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin

40. The combination of TAS-102 and bevacizumab as the third-line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study).

41. Transanal TME: new standard or fad?

42. Study Protocol of Regorafenib Escalation for Colorectal Cancer (RECC): A Phase II Multicenter Clinical Trial of the Efficacy and Safety of Regorafenib Dose Escalation Therapy as the Third or Fourth Line Therapy for Unresectable/Recurrent Colorectal Cancer

46. Efficacy of Abdominal Fascia and Skin Closure Using Triclosan-Coated Sutures on Incidence of Superficial Incisional Surgical Site Infections after Gastroenterologic Surgery

Catalog

Books, media, physical & digital resources